Bioharvest Sciences Inc. and Batory Foods Announce the First Significant B2B VINIA Sale in the US Biotech Investing
IMBRUVICA® U.S. Prescribing Information Updated to Include Long-Term Data for Waldenström's Macroglobulinemia Biotech Investing
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine Pharmaceutical Investing
Bristol Myers Squibb Announces Update on Phase 3 CheckMate -548 Trial Evaluating Patients with Newly Diagnosed MGMT-Methylated Glioblastoma Multiforme Biotech Investing
Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19 Pharmaceutical Investing
Amgen Licenses AMG 634, An Investigational Treatment For Tuberculosis And Leprosy, To Medicines Development for Global Health Biotech Investing
Pfizer Invites Public to View and Listen to Webcast of February 2 Conference Call with Analysts Pharmaceutical Investing
Amgen Submits Sotorasib Marketing Authorization Application To The European Medicines Agency Biotech Investing
Hollister Biosciences Inc.'s Direct to Consumer Cannabis Delivery Platform, Dreamy Delivery Launches 2nd Depot in Sacramento, California Psychedelics Investing
